Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen-Reference-Cited by-同舟云学术

Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen

Published:1993-05 Issue:3 Volume:36 Page:185-190
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Weiner Louis M.,Hudes Gary R.,Kitson Joanne,Walczak Judy,Watts Perry,Litwin Samuel,O'Dwyer Peter J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01741090.pdf

Reference29 articles.

1. Ades E, Hinson A, Butler L (1986) Natural cytolytic activity in mice with natural or induced cellular defects. Cell Immunol 101: 15

2. Ardalan B, Singh G, Silberman H (1988) A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or withoutN-(phosphonacetyl)-l-aspartic acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 6: 1053

3. Ben-Efraim S, Shoval S, Ophin R (1986) The difference between 5-fluorouracil and melphalan in their ability to promote antitumor immune response against MOPC-315 plasmacytoma. Cancer 22: 43

4. Berenbaum MC (1979) The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil. Chemotherapy 25: 54

5. Blomgren SE, Wolberg WH, Kisken WA (1965) Effect of fluoropyrimidines on delayed cutaneous hypersensitivity. Cancer Res 25: 977

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of colorectal cancer upon host peripheral immune cell function;Colorectal Disease;2009-02-24

2. Review article: immune suppression and colorectal cancer;Alimentary Pharmacology and Therapeutics;2006-10

3. Combining cancer vaccines with chemotherapy;Expert Opinion on Pharmacotherapy;2005-11-30

4. In vitro and in vivo inhibition of myeloperoxidase with 5-fluorouracil;European Journal of Clinical Pharmacology;2001-11

5. Suppression by Anticancer Agents of Reactive Oxygen Generation from Polymorphonuclear Leukocytes;Free Radical Research;1996-01